Medicare Enrolled
Dr. Jason Boyd, MD
Hospitalist Physician · Goldsboro, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Boyd from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Boyd?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Boyd
Dr. Jason Boyd is a hospitalist physician in Goldsboro, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Boyd performed 94,508 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Boyd received a total of $2,544 from 55 pharmaceutical and/or device companies across 124 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Boyd is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 0% volume in NC
$2,544 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗94,508
Medicare services
Top 0% in NC for hospitalist physician
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 15,970 | $18 | $30 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
13,770 | $0 | $3 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
11,100 | $0 | $9 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
8,700 | $2 | $10 |
| Iron infusion (Monoferric) | 7,800 | $17 | $30 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
5,700 | $0 | $3 |
| Pembrolizumab injection (Keytruda) | 5,609 | $43 | $62 |
| Paclitaxel chemotherapy injection | 4,472 | $0 | $13 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,356 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,242 | $8 | $27 |
| Injection, tildrakizumab, 1 mg | 1,900 | $110 | $222 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,330 | $1 | $28 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,319 | $8 | $8 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
980 | $6 | $27 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
903 | $10 | $52 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
858 | $10 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
804 | $60 | $175 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
704 | $93 | $258 |
| Anti-nausea injection (ondansetron/Zofran) | 624 | $0 | $0 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
498 | $2 | $6 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
487 | $22 | $93 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
476 | $1 | $10 |
| Injection, leucovorin calcium, per 50 mg | 456 | $3 | $21 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
398 | $98 | $188 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
339 | $6 | $95 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
318 | $13 | $22 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
304 | $2 | $37 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
296 | $2 | $26 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
263 | $24 | $134 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
238 | $10 | $48 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
199 | $47 | $164 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
177 | $12 | $54 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
176 | $21 | $171 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
159 | $7 | $11 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
140 | $48 | $359 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
119 | $54 | $141 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
118 | $4 | $25 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
114 | $1 | $7 |
| Iron level test | 101 | $6 | $10 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
101 | $9 | $14 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
99 | $132 | $346 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
95 | $0 | $2 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
88 | $1 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
86 | $123 | $398 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
69 | $3 | $5 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
52 | $29 | $36 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
51 | $177 | $1,065 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
50 | $67 | $229 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
48 | $42 | $76 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
47 | $76 | $80 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
41 | $15 | $63 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
40 | $16 | $47 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
36 | $64 | $206 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
26 | $26 | $93 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
25 | $135 | $494 |
| New patient office visit, complex (60-74 min) | 21 | $157 | $496 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
16 | $101 | $275 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
24.8% high complexity
67.1% medium
8.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,544
Total received (2018-2024)
Avg $363/year across 7 years
Top 9% in NC for hospitalist physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
124
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$862
2023
$707
2022
$431
2021
$206
2020
$84
2019
$163
2018
$92
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$132
Janssen Biotech, Inc.
$125
Daiichi Sankyo Inc.
$65
Takeda Pharmaceuticals U.S.A., Inc.
$56
Eisai Inc.
$38
Celgene Corporation
$38
JAZZ PHARMACEUTICALS INC.
$38
Merck Sharp & Dohme LLC
$30
Regeneron Healthcare Solutions, Inc.
$27
AstraZeneca Pharmaceuticals LP
$26
SOBI, INC
$26
SERVIER PHARMACEUTICALS LLC
$23
E.R. Squibb & Sons, L.L.C.
$22
Dendreon Pharmaceuticals LLC
$22
RECORDATI_RARE_DISEASES_INC.
$22
Alexion Pharmaceuticals, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$20
Rigel Pharmaceuticals, Inc.
$19
GENZYME CORPORATION
$19
GlaxoSmithKline, LLC.
$17
MorphoSys, US Inc.
$16
BeiGene USA, Inc.
$15
Celltrion USA Inc.
$15
Genentech USA, Inc.
$15
PFIZER INC.
$13
Top 3 companies account for 37.3% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$194
Novartis Pharmaceuticals Corporation
$191
Takeda Pharmaceuticals U.S.A., Inc.
$126
Merck Sharp & Dohme LLC
$124
Incyte Corporation
$124
GENZYME CORPORATION
$110
Daiichi Sankyo Inc.
$96
AstraZeneca Pharmaceuticals LP
$93
PFIZER INC.
$87
Celgene Corporation
$84
Alnylam Pharmaceuticals Inc.
$74
Merck Sharp & Dohme Corporation
$55
Eisai Inc.
$55
Bayer Healthcare Pharmaceuticals Inc.
$52
JAZZ PHARMACEUTICALS INC.
$51
Genmab U.S., Inc.
$43
Genentech USA, Inc.
$42
G1 Therapeutics, Inc.
$42
Karyopharm Therapeutics Inc.
$39
ASD SPECIALTY HEALTHCARE, LLC
$39
Foundation Medicine, Inc.
$39
Alexion Pharmaceuticals, Inc.
$38
E.R. Squibb & Sons, L.L.C.
$38
Seattle Genetics, Inc.
$37
Exelixis Inc.
$35
Lilly USA, LLC
$35
ADC Therapeutics America, Inc.
$33
Stemline Therapeutics Inc.
$31
Bayer HealthCare Pharmaceuticals Inc.
$30
Regeneron Healthcare Solutions, Inc.
$27
SOBI, INC
$26
Gilead Sciences, Inc.
$24
Myovant Sciences Inc.
$24
Epizyme, Inc.,
$24
SERVIER PHARMACEUTICALS LLC
$23
AbbVie Inc.
$22
Dendreon Pharmaceuticals LLC
$22
RECORDATI_RARE_DISEASES_INC.
$22
EISAI INC.
$22
ARRAY BIOPHARMA INC
$21
Organon LLC
$20
Sobi, Inc
$20
Ipsen Biopharmaceuticals, Inc
$20
Rigel Pharmaceuticals, Inc.
$19
AVEO Pharmaceuticals, Inc.
$18
Acrotech Biopharma LLC
$17
Secura Bio, Inc.
$17
GlaxoSmithKline, LLC.
$17
MorphoSys, US Inc.
$16
BeiGene USA, Inc.
$15
Celltrion USA Inc.
$15
Puma Biotechnology, Inc.
$14
Pharmacyclics LLC, An AbbVie Company
$13
Acrotech Biopharma Inc.
$13
Astellas Pharma US Inc
$13
Top 3 companies account for 20.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · Alecensa · BELEODAQ · BOSULIF · BRAFTOVI · BRUKINSA · CALQUENCE · CARVYKTI · CERDELGA · CEREZYME · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · ELIQUIS · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Epkinly · FARYDAK · FOTIVDA · FOUNDATIONONE · GIVLAARI · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · JEVTANA · KEYTRUDA · KISQALI · LIBTAYO · LUTATHERA · Lenvima · MEKINIST · MONJUVI · NINLARO · Nubeqa · ONTRUZANT · OPDIVO · ORGOVYX · Orserdu · PLUVICTO · PROVENGE · Perjeta · Pomalyst · REBLOZYL · Rezlidhia · SARCLISA · SYLVANT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TALVEY · TAZVERIK · Tibsovo · Trodelvy · ULTOMIRIS · VEGZELMA · VENCLEXTA · VERZENIO · VONJO · Venclexta · XPOVIO · XTANDI · Xospata · ZEJULA · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hospitalist physicians in nearby ZIP areas
13
County median income
$58,082
Nearest hospital to ZIP centroid (approximate)
UNC HEALTH CARE WAYNE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Boyd is a mixed practice specialist, with above-average Medicare volume (top 0% in NC), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Boyd experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Boyd performed 15,970 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Boyd receive payments from pharmaceutical companies?
Yes. Dr. Boyd received a total of $2,544 from 55 companies across 124 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Boyd's costs compare to other hospitalist physicians in Goldsboro?
Dr. Boyd's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Boyd) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hospitalist Physicians in Goldsboro
Browse hospitalist physicians in Goldsboro ranked by procedure volume and transparency data.
Highest volume
Top Hospitalist Physicians in NC
Hospitalist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hospitalist Physicians in NC
Which NC hospitalist physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology